Many systemic inflammatory markers such as serum C-reactive protein (CRP), neutrophil-lymphocyte ratio (NLR), or platelet-lymphocyte ratio (PLR) have been shown to be a prognostic marker in various kinds of human cancers such as lung, colorectal, ovarian, and endometrial cancer [9–12]. Here, CRP is linked to cancer.